It has been previously reported that sauna therapy, a thermal therapy, improves the hemodynamics and clinical symptoms in patients with chronic heart failure and also improves endothelial function, which is impaired in such patients. The present study investigated whether the improvements observed with sauna therapy are through modulation of arterial endothelial nitric oxide synthase (eNOS) expression. Eight male Syrian golden hamsters underwent sauna therapy, using an experimental far infrared-ray dry sauna system, at 39°C for 15 min followed by 30°C for 20 min daily for 4 weeks. Control group hamsters were placed in the sauna system switched off at room temperature of 24°C for 35 min. Immunohistochemistry found greater amounts of the immunoreactive products of eNOS in the endothelial cells of the aorta and carotid, femoral and coronary arteries in the sauna group than in the control group. Western blot analysis also revealed that 4-week sauna therapy significantly increased eNOS expression in aortas by 50% in 4 series of independent experiments with an identical protocol (p<0.01). In reverse transcription polymerase chain reaction assay, the eNOS mRNA in aortas was greater in the sauna group than in controls, with a peak at 1-week of sauna therapy (approximately 40-fold increase). In conclusion, repeated thermal therapy upregulates eNOS expression in arterial endothelium. 
P EXPERIMENTAL INVESTIGATIONS
were harvested, rapidly frozen, and stored at -80°C. Four series of independent experiments were performed with the same protocol to quantify the eNOS expression by Western blot analysis.
Temperature and Hemodynamic Measurements
In a group of 5 additional hamsters, we measured the rectal temperature, using a Thermister thermometer (Sibaura, Tokyo, Japan), and systolic and diastolic blood pressure (SBP and DBP) and heart rate, using a Millar catheter pressure transducer (Millar Instruments, Houston, TX, USA) cannulated into the right carotid artery, immediately after anesthetization with pentobarbital sodium (50 mg/kg ip). Hemodynamic parameters were recorded on a computer using the Mac Lab system (AD Instruments, Castle Hill, NSW, Australia).
Immunohistochemistry
The labeled streptavidin biotin method was performed using a Histfine kit (Nichirei, Tokyo, Japan). Briefly, crosssections of arteries were incubated overnight with rabbit polyclonal eNOS antibodies (Santa Cruz Biotechnology, Santa Cruz, CA, USA), diluted 1:500, at 4°C and then incubated with biotinylated anti-rabbit IgG at room temperature for 30 min. The specimens were developed with diaminobenzidine and counterstained with hematoxylin.
Western Blot Analysis
Protein Preparation We obtained sample proteins according to the method described previously. 14 Briefly, crude homogenates of aortas suspended in a homogenizing buffer of 50 mmol/L Tris-HCl at pH 7
mol/L leupeptin, and 1 mol/L (p-amidinophenyl) methanesulfonyl fluoride were ultracentrifuged to collect the cytosolic fractions. The pellets were solubilized in a homogenizing buffer containing 10% glycerol and 20 mmol/L 3-[(3-chol-amidopropyl) dimethylammonino]-1-propanesulfonate and ultracentrifuged to extract the particulate fractions.
Western Blot Analysis Western blot analysis was performed using the NuPAGE Electrophoresis System (NOVEX, San Diego, CA, USA). Briefly, 10-g protein samples from either the cytosolic or particulate fractions were electrophoresed and transferred to a nitrocellulose membrane. The membrane was incubated overnight with rabbit polyclonal eNOS antibodies at 4°C, diluted 1:1,000, and incubated with anti-rabbit IgG antibodies conjugated with horseradish peroxidase (Santa Cruz Biotechnology) at room temperature (dilution 1:1,000) for 30 min. The bands were detected using an enhanced chemiluminescence detection kit (Amersham Pharmacia, Buckinghamshire, UK) and exposed to X-ray film. We confirmed that the amounts of proteins loaded on the gel were equal by Coomassie blue staining and quantified the densities of the bands by scanning densitometry using NIH image computer software (NIH, Bethesda, MD, USA).
RT-PCR Assay
Aortas were taken from each of 6 extra hamsters before the sauna therapy began and then on the day after 3-days', 1-week', 2-weeks', and 4-weeks' sauna therapy. Total RNA was extracted by the acid guanidinium thiocyanate-phenolchloroform method described previously. 15 To adjust the volume of the RNA sample, diethylpyrocarbonate-treated water was added to a total volume of 10 l for 1 g of RNA, after which 1 l of random hexamers (Takara biochemicals, Otsu, Japan) was added and heated at 70°C for 2 min. Then 5 l of 5 × reverse transcriptase buffer (250mmol/L Tris-HCl at pH 8.3, 375 mmol/L KCl, and 15 mmol/L MgCl2; Gibco BRL, Grand Island, NY, USA), 2.5 l of 0.1 mol/L DTT, 5 l of 2.5 mmol/L dNTPs, 0.5 l of 200 U/ l reverse transcriptase (Gibco BRL) and 1 l of ribonuclease inhibitor at 20 U/ l (Takara biochemicals) were added. Reactions were incubated at 37°C for 60 min and then at 70°C for 5 min. PCR was performed using a PCR kit (Takara biochemicals). Primers for eNOS and -actin, used as a positive control, were synthesized according to sequences published previously. 16 , 17 The primer for eNOS corresponded to 5'-TACG-GAGCAGCAAATCCAC-3' (sense) and 5'-CAGGCTGC-AGTCCTTTGAT-3' (antisense), and the primer for -actin corresponded to 5'-GCATCCTCACCCTGAAGTACCCCA-3' (sense) and 5'-ACTCGTCATACTCCTGCTTGCTGAT-3' (antisense). PCR was performed in a total volume of 50 l containing 1 l cDNA, 5 l of 10 × PCR buffer (20 mmol/L Tris-HCl at pH 8.0, 100 mmol/L KCl, 0.1 mmol/L EDTA, 1 mmol/L DTT, 0.5% Tween 20, 0.5% Nonidet P-40 and 50% Glycerol), 0.2 mmol/L dNTPs, 0.4 mol/L primers and 0.5 l of Taq DNA polymerase. The mixed samples were heated to 94°C for 150 s and then cycled as follows: denaturation at 94°C for 60 s, primer annealing at 53°C for eNOS and 55°C for -actin for 1 min, and extension at 72°C for 1 min for 32 cycles. Final extension was at 72°C for 7 min. PCR products were subjected to electrophoresis on a 1% agarose gel and then stained with ethidium bromide. The expected size of the eNOS PCR product was 819 bp, and that of -actin was 906 bp, as in a preliminary study, we had found that these PCR cycles were within the linear phase of amplification. The quantity of the product was in proportion to the amount of cDNA used. The densities of the bands of the PCR products were estimated using NIH image computer software.
Statistical Analysis
All values are given as the mean ± SD, and statistical significance was set at p<0.05. Unpaired t test was used for comparison between control and sauna group, and ANOVA was used for comparison of changes of hemodynamic parameters.
Results

Body Weight, Temperature, and Hemodynamic Measurements
There were no significant differences in the percentage of body weight gain and the ratio of whole heart weight to body weight between the 2 groups ( Table 1 ). The rectal temperature of the hamsters rose by approximately 1°C following a 15-min 39°C sauna, and was maintained by a 20-min sauna at 30°C (Table 2) . Heart rates did not show any change throughout the sauna nor between the first and 28th sauna. SBP and DBP did not change before or after the 1st sauna, but the post-sauna pressures were lower than the pre-sauna pressures at the 28th sauna (Table 2) . Furthermore, the SBP and DBP before the 28th sauna were lower than those before the 1st sauna (Table 2) .
Immunohistochemistry
Immunoreactive products of eNOS were identified in the endothelial cells of aortas and coronary arteries in the control group, but the immunoreactivity was stronger in the sauna group than in the control group (Fig 1) . The immunoreactive products were barely detectable in the media and adventitia of either group (Fig 1) . These results were reproduced in each series. Immunoreactivity also increased in the endothelium of the carotid and femoral arteries.
Western Blot Analysis
Western blot analysis revealed that eNOS expression Immunoreactive products of eNOS were identified in the endothelial cells of arteries, and immunoreactivity was stronger in hamsters given sauna therapy than in untreated controls. Only minimal amounts of immunoreactive product were detected in the media and adventitia of either group. Aorta in (A) controls, (B) the sauna group; Coronary artery in (C) controls and (D) the sauna group (×100).
(135 kDa) was greater in the particulate fraction of aortas from the sauna group than in that from the control group (Fig 2A) . Quantitative densitometric analysis confirmed that eNOS protein was significantly greater in the sauna group than in the control group (109±10 vs 74±16 n=8, p<0.01, Fig 2B) . There was no difference between the 2 groups in the eNOS expression in the cytosolic fraction.
RT-PCR Assay
We next examined the expression of eNOS mRNA using RT-PCR (Fig 3) . The eNOS mRNA in aortas, expressed as a percentage of -actin, was greater in the sauna group than in the control group, with a peak at 1-week of sauna therapy. The amount of eNOS mRNA expression at 1-week of sauna therapy increased approximately 40-fold in comparison with that in control group by densitometric analysis. The levels of RT-PCR products for -actin did not differ throughout the 4-week sauna therapy.
Discussion
The present study clarified that repeated sauna therapy upregulates eNOS protein and mRNA in the arterial endothelium by immunohistochemistry, Western blot analysis and RT-PCR assay. Several recent studies have established that the endothelium-dependent vasodilatory response is attenuated in CHF because of decreased NO production and increased degradation of NO. [9] [10] [11] Patients with CHF have reduced cardiac output and decreased peripheral blood flow, resulting in a decrease in shear stress, and it is thought that these changes decrease NO production and downregulate eNOS. Smith et al have shown that eNOS protein is markedly reduced in the thoracic aorta of dogs with pacing-induced heart failure, 12 and similar results have been reported in rats with heart failure. 13 The hemodynamic changes induced by sauna in the present study (Table 2 ) might have been caused by an increase in NO production in vessels, such as the aorta and carotid, femoral and coronary arteries, thus decreasing cardiac afterload, increasing cardiac output and coronary flow, and improving the systemic hemodynamics, endothelial function and cardiac function. In our clinical study, repeated sauna therapy reduced clinical symptoms in patients with CHF and decreased plasma concentrations of brain natriuretic peptide, secondary to improved peripheral circulation (unpublished data).
ACE inhibitors decrease plasma angiotensin II and increase bradykinin concentrations and thus increase NO bioavailability. 18 Interestingly, exercise has been reported to also improve endothelial function in patients with CHF [19] [20] [21] and to normalize decreased eNOS expression in an animal model of CHF. 22, 23 We believe that eNOS upregulation induced by sauna is caused by an increase in cardiac output and blood flow, 4 which in turn results in increased shear stress. It is possible that thermal stimulation upregulates arterial eNOS directly. Another possibility is the involvement of tumor necrosis factor-(TNF-), because it downregulates eNOS expression. 24 However, the precise mechanisms remain to be determined.
Although the thermoregulatory mechanisms are quite different between humans and hamsters, we observed that blood flow in the aortas of hamsters significantly increased during sauna treatment, as demonstrated clinically in patients with heart failure and normal subjects. 4 It is an important point whether sauna therapy was stressful, or harmful, to the hamsters, but is unlikely because heart rates did not change during the sauna therapy and there was no difference in body weight between the 2 groups at the end of the 4-week sauna therapy. Furthermore, careful observation ensured that the hamsters were kept calm, and were not excited or suffering, during the sauna therapy, so their behavior was quite similar to that of the control hamsters kept in the switched-off sauna system. This study was performed in healthy animals, and the next step is to examine the effect of sauna therapy in animals with CHF.
